Shandong Weigao Blood Purification Products Co (SHSE:603014) Other Stockholders Equity: ¥4,984 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:603014 Shandong Weigao Blood Purification Products Co Ltd SHSE:603014
39 GF Score
Price ¥33.87
! 3 Warning Signs
View Full Analysis

What is Shandong Weigao Blood Purification Products Co Other Stockholders Equity?

Shandong Weigao Blood Purification Products Co SHSE:603014 -0.67% 39 Other Stockholders Equity is ¥4,984 Mil as of Mar. 2026. GuruFocus rates SHSE:603014 with a GF Score™ of 39/100. The stock has 3 warning signs investors should review.

Shandong Weigao Blood Purification Products Co's Other Stockholders Equity for the quarter that ended in Mar. 2026 was ¥4,984 Mil.

Shandong Weigao Blood Purification Products Co's quarterly Other Stockholders Equity declined from Sep. 2025 (¥4,963 Mil) to Dec. 2025 (¥941 Mil) but then increased from Dec. 2025 (¥941 Mil) to Mar. 2026 (¥4,984 Mil).

Shandong Weigao Blood Purification Products Co's annual Other Stockholders Equity increased from Dec. 2023 (¥-1,165 Mil) to Dec. 2024 (¥569 Mil) and increased from Dec. 2024 (¥569 Mil) to Dec. 2025 (¥941 Mil).

Shandong Weigao Blood Purification Products Co Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Shandong Weigao Blood Purification Products Co's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shandong Weigao Blood Purification Products Co Other Stockholders Equity Chart

Shandong Weigao Blood Purification Products Co Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Stockholders Equity
Get a 7-Day Free Trial -1,663.57 -5,495.90 -1,164.79 569.18 941.18

Shandong Weigao Blood Purification Products Co Quarterly Data
Dec20 Dec21 Dec22 Jun23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3,901.79 933.48 4,963.39 941.18 4,983.54
SHSE:603014
39GF Score
Shandong Weigao Blood Purification Products Co Ltd SHSE:603014
Other Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shandong Weigao Blood Purification Products Co Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of ¥4,984 Mil mean?
Shandong Weigao Blood Purification Products Co (SHSE:603014) has a Other Stockholders Equity of ¥4,984 Mil as of Mar. 2026. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Shandong Weigao Blood Purification Products Co and its competitors.
Is Shandong Weigao Blood Purification Products Co's Other Stockholders Equity too high?
Shandong Weigao Blood Purification Products Co's current Other Stockholders Equity is ¥4,984 Mil. Overall, Shandong Weigao Blood Purification Products Co has a GF Score™ of 39/100, reflecting its overall financial health beyond just this single metric.
How does Shandong Weigao Blood Purification Products Co's Other Stockholders Equity compare to ABT and SYK?
Shandong Weigao Blood Purification Products Co's Other Stockholders Equity of ¥4,984 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Medical Devices & Instruments company?
A good Other Stockholders Equity depends on the Medical Devices & Instruments industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Shandong Weigao Blood Purification Products Co and its competitors. Shandong Weigao Blood Purification Products Co's current Other Stockholders Equity is ¥4,984 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shandong Weigao Blood Purification Products Co stock overvalued right now?
Shandong Weigao Blood Purification Products Co (SHSE:603014) has a current Other Stockholders Equity of ¥4,984 Mil. The current Other Stockholders Equity is ¥4,984 Mil. Shandong Weigao Blood Purification Products Co's overall GF Score™ is 39/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Shandong Weigao Blood Purification Products Co (SHSE:603014), the current Other Stockholders Equity is ¥4,984 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Shandong Weigao Blood Purification Products Co Business Description

Address No. 7, Weigao West Road, Torch High-tech Industrial Development Zone, Shandong Province, Weihai, CHN, 264200
Shandong Weigao Blood Purification Products Co Ltd engaged in research and development, production and sales of blood purification medical products.
39GF Score

Get the complete analysis for SHSE:603014

Other Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥33.87
Price